Sitagliptin
ATC Code
A10BH01
Sitagliptin
Definition
An orally available, competitive, beta-amino acid-derived inhibitor of dipeptidyl peptidase 4 (DDP-4) with hypoglycemic activity. Sitagliptin may cause an increased risk in the development of pancreatitis.
Also known as SITAGLIPTIN — per NCIT
Also identified as
- ATC A10BH01 per RXNORM
- NCIT NCIT:C73838 per NCIT
- SCTID 423307000 per RXNORM
- SCTID 424106006 per RXNORM
- UNII QFP0P1DV7Z per RXNORM
Indications
| Disease | Relation | Source |
|---|---|---|
| Diabetes mellitus type 2 | may treat | MEDRT · Public domain (U.S. Government work) |
Organ Effects
| Organ | Side effect / interaction | Source |
|---|---|---|
| Alimentary part of gastrointestinal system | may treat a disease of this organ | DERIVED · CC BY 4.0 |
| Pancreas | may treat a disease of this organ | DERIVED · CC BY 4.0 |
2 entries above are marked DERIVED: Atlas Médico inferred them by combining two sourced claims, and no source asserts these links directly. Treat them as a navigation aid, not as a clinical statement.